home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

UAT and Risk Mitigation: Insights from Global Technology Experts and Cutting-Edge Pharma

 
  July 31, 2023  
     
 
Xtalks, online
2023 -9-07


In the dynamic landscape of clinical trials, ensuring efficient and compliant User Acceptance Testing (UAT) processes while mitigating risks is crucial. In this engaging webinar, leading technology vendors, 4G Clinical and Poxy Clinical, collaborated with renowned pharmaceutical company, Vir Biotechnology, to present their approach in supporting complex trial UAT. The webinar will explore the interpretation of regulations, the implementation of GAMP 5 guidelines and the integration of best practices from this partnership. This insightful webinar aims to assist sponsors on their UAT journey while minimizing potential risks.
 
During the webinar, the featured speakers will also highlight how efficient and enhanced UAT processes allow sponsors to concentrate on core aspects of the trial. By fostering a more efficient and inclusive UAT experience, this collaborative approach not only supports risk mitigation efforts but also contributes to optimized and compliant clinical trials.
 
Join the speakers to gain valuable insights and strategies for enhancing UAT processes while minimizing risks.
 
 
Organized by: Xtalks
Invited Speakers: Jordan Clark, Manager, Clinical Operations Manager, Vir Biotechnology Susan Vong, President, Poxy Clinical, UAT Services Savannah Alford, Delivery Operations Manager, 4G Clinical
 
Deadline for Abstracts: 2023 -9-07
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.